These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18021388)

  • 1. Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.
    Enevold A; Nkya WM; Theisen M; Vestergaard LS; Jensen AT; Staalsoe T; Theander TG; Bygbjerg IC; Alifrangis M
    Malar J; 2007 Nov; 6():153. PubMed ID: 18021388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
    Mbacham WF; Evehe MS; Netongo PM; Ateh IA; Mimche PN; Ajua A; Nji AM; Irenee D; Echouffo-Tcheugui JB; Tawe B; Hallett R; Roper C; Targett G; Greenwood B
    Malar J; 2010 Jan; 9():34. PubMed ID: 20105282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
    Aubouy A; Migot-Nabias F; Deloron P
    Infect Genet Evol; 2007 Mar; 7(2):147-54. PubMed ID: 16890498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.
    Aubouy A; Bakary M; Keundjian A; Mbomat B; Makita JR; Migot-Nabias F; Cot M; Le Bras J; Deloron P
    Antimicrob Agents Chemother; 2003 Jan; 47(1):231-7. PubMed ID: 12499196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.
    Mahaman Moustapha L; Adamou R; Ibrahim ML; Abdoulaye Louis Padounou M; Diallo A; Courtin D; Testa J; Ndiaye JLA
    Malar J; 2021 Jan; 20(1):1. PubMed ID: 33386070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
    Mockenhaupt FP; Ehrhardt S; Dzisi SY; Teun Bousema J; Wassilew N; Schreiber J; Anemana SD; Cramer JP; Otchwemah RN; Sauerwein RW; Eggelte TA; Bienzle U
    Trop Med Int Health; 2005 Jun; 10(6):512-20. PubMed ID: 15941413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Lemnge MM; Ali AS; Malecela EK; Sambu E; Abdulla R; Juma MS; Fakih K; Abdulla KH; Njau RJ
    Am J Trop Med Hyg; 2005 Oct; 73(4):681-5. PubMed ID: 16222009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Schellenberg D; Kahigwa E; Drakeley C; Malende A; Wigayi J; Msokame C; Aponte JJ; Tanner M; Mshinda H; Menendez C; Alonso PL
    Am J Trop Med Hyg; 2002 Jul; 67(1):17-23. PubMed ID: 12363058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
    Nsimba B; Guiyedi V; Mabika-Mamfoumbi M; Mourou-Mbina JR; Ngoungou E; Bouyou-Akotet M; Loembet R; Durand R; Le Bras J; Kombila M
    Malar J; 2008 Feb; 7():31. PubMed ID: 18267042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.